Research work · 2020
PharmVar GeneFocus: CYP2C19
Mariana Rodrigues Botton, Michelle Whirl‐Carrillo, Andria Lee Del Tredici, Katrin Sangkuhl, Larisa H. Cavallari, José A. G. Agúndez, Jorge Duconge-Soler, Ming Ta Michael Lee, Erica L. Woodahl, Karla Claudio‐Campos, Ann K. Daly, Teri E. Klein, Victoria M. Pratt, Stuart Alexander Scott, Andrea Gaedigk
Clinical Pharmacology & Therapeutics
Abstract
The Pharmacogene Variation Consortium (PharmVar) catalogues star (*) allele nomenclature for the polymorphic human CYP2C19 gene. CYP2C19 genetic variation impacts the metabolism of many drugs and has been associated with both efficacy and safety issues for several commonly prescribed medications. This GeneFocus provides a comprehensive overview and summary of CYP2C19 and describes how haplotype information catalogued by PharmVar is utilized by the Pharmacogenomics Knowledgebase and the Clinical Pharmacogenetics Implementation Consortium (CPIC).
DOI: 10.1002/cpt.1973